Ipca Lab Q4 net profit up 84% at Rs 137 cr

Drug firm Ipca Laboratories today posted 84.10% jump in net profit at Rs 137.03 crore for the fourth quarter ended March 31, 2013-14.

The company had reported net profit of Rs 74.43 crore during the January-March same period of the 2012-13 fiscal.

Net sales of the company during Q4, 2013-14 were Rs 739.81 crore, up 12.32% from Rs 658.64 crore in the year-ago period, Ipca Laboratories said in a filing to the BSE.

The company's Q4 revenue from domestic formulations business stood at Rs 196.56 crore, up 10%, while the revenue from exports stood at Rs 373.18 crore, up 19%.

The Ipca Labs scrip was trading at Rs 785 on the BSE in the afternoon trade, down 0.39% from the previous close.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Digging up carcasses from excavation sites is not going to take this nation forward

    The Bharat Ratna, bestowed by the world’s largest democracy as its highest civilian honour, “in recognition of exceptional service/performance of

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: THE EMPATHY GAP

The empathy gap (also known as the hot-cold empathy gap) ...

Zehra Naqvi

A thrilling journey

Amrita Chowdhury could well be India’s Jeffery Archer. Edge-of-the-seat thriller ...

Bubbles Sabharwal

Time to gift ourselves some good cheer

The other day, my labrador Cesar asked me, “You do ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture